154 related articles for article (PubMed ID: 9047157)
1. Hyperacute lung rejection in a pig-to-human transplant model: the role of anti-pig antibody and complement.
Pierson RN; Kasper-Konig W; Tew DN; Young VK; Dunning JJ; Horsley J; Carey NR; Wallwork J; White DJ
Transplantation; 1997 Feb; 63(4):594-603. PubMed ID: 9047157
[TBL] [Abstract][Full Text] [Related]
2. Hyperacute lung rejection in the pig-to-human model. 2. Synergy between soluble and membrane complement inhibition.
Azimzadeh A; Zorn GL; Blair KS; Zhang JP; Pfeiffer S; Harrison RA; Cozzi E; White DJ; Pierson RN
Xenotransplantation; 2003 Mar; 10(2):120-31. PubMed ID: 12588645
[TBL] [Abstract][Full Text] [Related]
3. Hyperacute lung rejection in the pig-to-human model 4: evidence for complement and antibody independent mechanisms.
Pfeiffer S; Zorn GL; Blair KS; Farley SM; Wu G; Schuurman HJ; White DJ; Azimzadeh AM; Pierson RN
Transplantation; 2005 Mar; 79(6):662-71. PubMed ID: 15785372
[TBL] [Abstract][Full Text] [Related]
4. Complement inhibition by FUT-175 and K76-COOH in a pig-to-human lung xenotransplant model.
Blum MG; Collins BJ; Chang AC; Zhang JP; Knaus SA; Pierson RN
Xenotransplantation; 1998 Feb; 5(1):35-43. PubMed ID: 9507731
[TBL] [Abstract][Full Text] [Related]
5. Ex vivo lung model of pig-to-human hyperacute xenograft rejection.
Macchiarini P; Mazmanian GM; Oriol R; de Montpreville V; Dulmet E; Fattal S; Libert JM; Doubine S; Nochy D; Rieben R; Dartevelle P
J Thorac Cardiovasc Surg; 1997 Sep; 114(3):315-25. PubMed ID: 9305182
[TBL] [Abstract][Full Text] [Related]
6. Immunohistologic evaluation of mechanisms mediating hyperacute lung rejection, and the effect of treatment with K76-COOH, FUT-175, and anti-Gal column immunoadsorption.
Zhang JP; Blum MG; Chang AC; Shyr Y; Blair KS; Awwad M; Pierson RN
Xenotransplantation; 1999 Nov; 6(4):249-61. PubMed ID: 10704068
[TBL] [Abstract][Full Text] [Related]
7. Hyperacute rejection of mouse lung by human blood: characterization of the model and the role of complement.
Schröder C; Wu GS; Price E; Johnson JE; Pierson RN; Azimzadeh AM
Transplantation; 2003 Sep; 76(5):755-60. PubMed ID: 14501848
[TBL] [Abstract][Full Text] [Related]
8. Transgenic swine lungs expressing human CD59 are protected from injury in a pig-to-human model of xenotransplantation.
Kulick DM; Salerno CT; Dalmasso AP; Park SJ; Paz MG; Fodor WL; Bolman RM
J Thorac Cardiovasc Surg; 2000 Apr; 119(4 Pt 1):690-9. PubMed ID: 10733757
[TBL] [Abstract][Full Text] [Related]
9. Evidence of human non-alpha-galactosyl antibodies involved in the hyperacute rejection of pig lungs and their removal by pig organ perfusion.
Macchiarini P; Oriol R; Azimzadeh A; de Montpreville V; Rieben R; Bovin N; Mazmanian M; Dartevelle P
J Thorac Cardiovasc Surg; 1998 Nov; 116(5):831-43. PubMed ID: 9806390
[TBL] [Abstract][Full Text] [Related]
10. Potential of an injectable polymer to prevent hyperacute rejection of ex vivo perfused porcine lungs.
Wiebe K; Oezkur M; Pöling J; Haverich A
Transplantation; 2006 Sep; 82(5):681-8. PubMed ID: 16969293
[TBL] [Abstract][Full Text] [Related]
11. Complement inhibition with an anti-C5 monoclonal antibody prevents acute cardiac tissue injury in an ex vivo model of pig-to-human xenotransplantation.
Kroshus TJ; Rollins SA; Dalmasso AP; Elliott EA; Matis LA; Squinto SP; Bolman RM
Transplantation; 1995 Dec; 60(11):1194-202. PubMed ID: 8525509
[TBL] [Abstract][Full Text] [Related]
12. Antibody removal by column immunoabsorption prevents tissue injury in an ex vivo model of pig-to-human xenograft hyperacute rejection.
Kroshus TJ; Dalmasso AP; Leventhal JR; John R; Matas AJ; Bolman RM
J Surg Res; 1995 Jul; 59(1):43-50. PubMed ID: 7630135
[TBL] [Abstract][Full Text] [Related]
13. Selective IgM depletion prolongs organ survival in an ex vivo model of pig-to-human xenotransplantation.
Kroshus TJ; Bolman RM; Dalmasso AP
Transplantation; 1996 Jul; 62(1):5-12. PubMed ID: 8693544
[TBL] [Abstract][Full Text] [Related]
14. Low molecular weight dextran sulfate prevents complement activation and delays hyperacute rejection in pig-to-human xenotransplantation models.
Fiorante P; Banz Y; Mohacsi PJ; Kappeler A; Wuillemin WA; Macchiarini P; Roos A; Daha MR; Schaffner T; Haeberli A; Mazmanian GM; Rieben R
Xenotransplantation; 2001 Feb; 8(1):24-35. PubMed ID: 11208188
[TBL] [Abstract][Full Text] [Related]
15. Profound pulmonary hypertension characteristic of pig lung rejection by human blood is mediated by xenoreactive antibody independent of complement.
Pierson RN; Kaspar-König W; Tew DN; Young VK; Braidley PC; White DJ; Wallwork J
Transplant Proc; 1995 Feb; 27(1):274. PubMed ID: 7879001
[No Abstract] [Full Text] [Related]
16. Prolongation of cardiac xenograft survival by depletion of complement.
Leventhal JR; Dalmasso AP; Cromwell JW; Platt JL; Manivel CJ; Bolman RM; Matas AJ
Transplantation; 1993 Apr; 55(4):857-65; discussion 865-6. PubMed ID: 8475561
[TBL] [Abstract][Full Text] [Related]
17. Expression of human decay accelerating factor may protect pig lung from hyperacute rejection by human blood.
Pierson RN; Pino-Chavez G; Young VK; Kaspar-Konig W; White DJ; Wallwork J
J Heart Lung Transplant; 1997 Feb; 16(2):231-9. PubMed ID: 9059935
[TBL] [Abstract][Full Text] [Related]
18. Human complement regulatory proteins protect swine lungs from xenogeneic injury.
Yeatman M; Daggett CW; Lau CL; Byrne GW; Logan JS; Platt JL; Davis RD
Ann Thorac Surg; 1999 Mar; 67(3):769-75. PubMed ID: 10215226
[TBL] [Abstract][Full Text] [Related]
19. Hyperacute rejection in ex vivo-perfused porcine lungs transgenic for human complement regulatory proteins.
Pöling J; Oezkur M; Kogge K; Mengel M; Niemann H; Winkler M; Haverich A; Wiebe K
Transpl Int; 2006 Mar; 19(3):225-32. PubMed ID: 16441772
[TBL] [Abstract][Full Text] [Related]
20. The immunopathology of cardiac xenograft rejection in the guinea pig-to-rat model.
Leventhal JR; Matas AJ; Sun LH; Reif S; Bolman RM; Dalmasso AP; Platt JL
Transplantation; 1993 Jul; 56(1):1-8. PubMed ID: 8333031
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
